Document:

Private Placement Subscription Agreement

  
 Exhibit 4.1

 THIS PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT RELATES TO AN OFFERING OF SECURITIES NOT INVOLVING ANY PUBLIC OFFERING PURSUANT TO
REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”). 
 NONE OF THE SECURITIES TO WHICH
THIS PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT (THE “AGREEMENT”) RELATES HAVE BEEN REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, IN THE
UNITED STATES OR TO U.S. PERSONS (AS DEFINED HEREIN) EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF 1933 ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT
SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN ACCORDANCE WITH THE 1933
ACT. 
 CONFIDENTIAL 
 PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT 
  

			
	TO:	 	FNDS3000 Corp (the “Company”)
		 	4651 Salisbury Road, Suite 485
		 	Jacksonville, FL 32256
		 	United States of America

 Purchase of
Securities 
 1. Subscription 
  

	1.1	The undersigned (the “Subscriber”) hereby irrevocably subscribes for and agrees to purchase (i) 5,638,890 shares of the common stock of the
Company at a price per share of USD $0.175 (the “Shares”); and (ii) 5,638,890 common stock purchase warrants with an exercise price of USD $0.175 (the “Warrants”) (such subscription and agreement to purchase
being the “Subscription”), for an aggregate purchase price of USD $986,805.75 (the “Subscription Proceeds”). Each Warrant will entitle the holder to purchase one additional Share for a period of 24 months from the
Closing Date (the “Underlying Shares”). The Shares, Warrants and Underlying Shares together referred to herein as the “Securities.” 

 

	1.2	On the basis of the representations and warranties and subject to the terms and conditions set forth herein, the Company hereby irrevocably agrees to sell the Shares,
Warrants and Underlying Shares to the Subscriber. 

  

	1.3	Subject to the terms hereof, the Subscription will be effective upon its acceptance by the Company. 

 

	1.4	The form of Warrant is attached hereto as Exhibit A. 

  
 2. Payment 

 

	2.1	The Subscription Proceeds must accompany this Subscription and shall be paid by certified check or bank draft drawn on a United States chartered bank, and made payable
and delivered to the Company. Alternatively, the Subscription Proceeds may be wired to the Company pursuant to wiring instructions that will be provided to the Subscriber upon request. 

 

	2.2	The Subscriber acknowledges and agrees that this Agreement, the Subscription Proceeds and any other documents delivered in connection herewith will be held on behalf of
the Company. In the event that this Agreement is not accepted by the Company for whatever reason, which the Company expressly reserves the right to do, within 30 days of the delivery of an executed Agreement by the Subscriber, this Agreement, the
Subscription Proceeds (without interest thereon) and any other documents delivered in connection herewith will be returned to the Subscriber at the address of the Subscriber as set forth in this Agreement. 

 

	2.3	Where the Subscription Proceeds are paid to the Company, the Company is entitled to treat such Subscription Proceeds as an interest-free loan to the Company until such
time as the Subscription is accepted and the certificates representing the Shares have been issued to the Subscriber. 

 3.
Documents Required from Subscriber 
  

	3.1	The Subscriber must complete, sign and return to the Company an executed copy of this Agreement. 

 

	3.2	The Subscriber shall complete, sign and return to the Company as soon as possible, on request by the Company, any documents, questionnaires, notices and undertakings as
may be required by regulatory authorities, and applicable law. 

 4. Closing. Closing of the purchase of the
Securities (the “Closing”) shall occur on or before October 19, 2010 or on such other date as may be determined by the Company (the “Closing Date”). 
 5. Acknowledgements of Subscriber 
  

	5.1	The Subscriber acknowledges and agrees that: 

  

	 	(a)	none of the Securities have been registered under the 1933 Act, or under any state securities or “blue sky” laws of any state of the United States, and,
unless so registered, may not be offered or sold in the United States or, directly or indirectly, except in accordance with the provisions of, and pursuant to an effective registration statement under, the 1933 Act, or pursuant to an exemption from,
or in a transaction not subject to, the registration requirements of the 1933 Act, and in each case in accordance with applicable state securities laws; 

  

	 	(b)	the decision to execute this Agreement and acquire the Securities hereunder has not been based upon any oral or written representation as to fact or otherwise made by
or on behalf of the Company; 

  

	 	(c)	neither the Securities and Exchange Commission nor any other securities commission or similar regulatory authority has reviewed or passed on the merits of the
Securities; 

  

	 	(d)	there is no government or other insurance covering any of the Securities; 

  

	 	(e)	there are risks associated with an investment in the Securities; 

  

	 	(f)	the Subscriber has not acquired the Securities as a result of, and will not itself engage in, any “directed selling efforts” (as defined under the 1933 Act)
in the United States in respect of the Securities which would include any activities undertaken for the purpose of, or that could reasonably be expected to have the effect of, conditioning the market in the United States for the resale of any of the
Securities; provided, however, that the Subscriber may sell or otherwise dispose of the Securities pursuant to registration thereof under the 1933 Act and any applicable state securities laws or under an exemption from such registration
requirements; 

  

	 	(g)	the Subscriber and the Subscriber’s advisor(s) have had a reasonable opportunity to ask questions of and receive answers from the Company in connection with the
distribution of the Securities hereunder, and to obtain additional information, to the extent possessed or obtainable without unreasonable effort or expense, necessary to verify the accuracy of information about the Company;

  

	 	(h)	the books and records of the Company were available upon reasonable notice for inspection, subject to certain confidentiality restrictions, by the Subscriber during
reasonable business hours at its principal place of business, and all documents, records and books in connection with the distribution of the Securities hereunder have been made available for inspection by the Subscriber, the Subscriber’s
lawyer and/or advisor(s); 

  

	 	(i)	the Subscriber will indemnify and hold harmless the Company and, where applicable, its directors, officers, employees, agents, advisors and shareholders, from and
against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all fees, costs and expenses whatsoever reasonably incurred in investigating, preparing or defending against any claim, lawsuit,
administrative proceeding or investigation whether commenced or threatened) arising out of or based upon any representation or warranty of the Subscriber contained herein or in any document furnished by the Subscriber to the Company in connection
herewith being untrue in any material respect or any breach or failure by the Subscriber to comply with any covenant or agreement made by the Subscriber to the Company in connection therewith; 

 

	 	(j)	the Company will refuse to register any transfer of the Securities not made in accordance with, or pursuant to an effective registration statement under, the 1933 Act
or pursuant to an available exemption from the registration requirements of the 1933 Act and in accordance with applicable state securities laws; 

  

	 	(k)	the Subscriber has been advised to consult the Subscriber’s own legal, tax and other advisors with respect to the merits and risks of an investment in the
Securities and with respect to applicable resale restrictions, and it is solely responsible (and the Company is not in any way responsible) for compliance with: 

 

	 	(i)	any applicable laws of the jurisdiction in which the Subscriber is resident in connection with the distribution of the Securities hereunder, and

  

	 	(ii)	applicable resale restrictions; 

  

	 	(l)	this Agreement is not enforceable by the Subscriber unless it has been accepted by the Company, and the Subscriber acknowledges and agrees that the Company reserves the
right to reject any subscription for any reason. 

 6. Representations, Warranties and Covenants of the Subscriber.
The Subscriber hereby represents and warrants to and covenants with the Company (which representations, warranties and covenants shall survive the Closing Date) that: 
  

	 	(a)	the Subscriber has the legal capacity and competence to enter into and execute this Agreement and to take all actions required pursuant hereto and, if the Subscriber is
a corporation or other legal entity, it is duly incorporated or organized and validly existing and in good standing under the laws of its jurisdiction of incorporation or organization and all necessary approvals by its directors, shareholders,
members, managers, owners and others have been obtained to authorize execution and performance of this Agreement on behalf of the Subscriber; 

  

	 	(b)	the entering into of this Agreement and the transactions contemplated hereby do not result in the violation of any of the terms and provisions of any law applicable to
the Subscriber or of any agreement, written or oral, to which the Subscriber may be a party or by which the Subscriber is or may be bound; 

  

	 	(c)	the Subscriber has duly executed and delivered this Agreement, and it constitutes a valid and binding agreement of the Subscriber enforceable against the Subscriber in
accordance with its terms; 

  

	 	(d)	the Subscriber is not acquiring the Securities for the account or benefit of, directly or indirectly, any U.S. Person; 

 

	 	(e)	the Subscriber is resident in the jurisdiction set out on the signature page of this Agreement; 

 

	 	(f)	the sale of the Securities to the Subscriber as contemplated in this Agreement complies with or is exempt from the applicable securities legislation of the jurisdiction
of residence of the Subscriber; 

  

	 	(g)	the Subscriber is acquiring the Securities for investment only and not with a view to resale or distribution and, in particular, it has no intention to distribute
either directly or indirectly any of the Securities in the United States or to U.S. Persons; 

  

	 	(h)	the Subscriber is acquiring the Securities as principal for the Subscriber’s own account, and not with a view to, or for, resale, distribution or fractionalization
thereof, in whole or in part, and no other person has a direct or indirect beneficial interest in such Securities; 

  

	 	(i)	the Subscriber is not an underwriter of, or dealer in, the common shares of the Company, nor is the Subscriber participating, pursuant to a contractual agreement or
otherwise, in the distribution of the Securities; 

  

	 	(j)	the Subscriber (i) is able to determine for him/her/itself the propriety of the Subscription; (ii) has such knowledge and experience in business matters as to
be capable of evaluating the merits and risks of its prospective investment in the Securities; and (iii) has the ability to bear the economic risks of its prospective investment and can afford the complete loss of such investment;

  

	 	(k)	the Subscriber acknowledges that the Subscriber has not acquired the Securities as a result of, and will not itself engage in, any “directed selling efforts”
(as defined under the 1933 Act) in the United States in respect of the Securities which would include any activities undertaken for the purpose of, or that could reasonably be expected to have the effect of, conditioning the market in the United
States for the resale of the Securities; provided, however, that the Subscriber may sell or otherwise dispose of the Securities pursuant to registration of the Securities pursuant to the 1933 Act and any applicable state securities laws or under an
exemption from such registration requirements and as otherwise provided herein; 

  

	 	(l)	the Subscriber understands and agrees that none of the Shares or Underlying Shares have been registered under the 1933 Act, or under any state securities or “blue
sky” laws of any state of the United States, and, unless so registered, may not be offered or sold in the United States or, directly or indirectly, to U.S. Persons except in accordance with the provisions of Regulation S, pursuant to an
effective registration statement under the 1933 Act, or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the 1933 Act; 

 

	 	(m)	the Subscriber understands and agrees not to engage in any hedging transactions involving any of the Securities unless such transactions are in compliance with the
provisions of the 1933 Act and in each case only in accordance with applicable state securities laws; 

  

	 	(n)	the Subscriber understands and agrees that the Company will refuse to register any transfer of the Securities not made in accordance with, and pursuant to an effective
registration statement under, the 1933 Act or pursuant to an available exemption from the registration requirements of the 1933 Act; 

  

	 	(o)	the Subscriber is not aware of any advertisement of any of the Securities and is not acquiring the Securities as a result of any form of general solicitation or general
advertising including advertisements, articles, notices or other communications published in any newspaper, magazine or similar media or broadcast over radio or television, or any seminar or meeting whose attendees have been invited by general
solicitation or general advertising; 

  

	 	(p)	the Subscriber has completed the Accredited Investor Questionnaire attached hereto as Exhibit B in a complete and accurate fashion; and 

 

	 	(q)	no person has made to the Subscriber any written or oral representations: 

  

	 	(i)	that any person will resell or repurchase any of the Securities, 

  

	 	(ii)	that any person will refund the purchase price of any of the Securities, or 

 

	 	(iii)	as to the future price or value of any of the Securities. 

  

	 	(r)	The Subscriber has reviewed the Company’s filings with the Securities and Exchange Commission, understands the business of the Company and has been afforded an
opportunity to ask questions of management. 

  

	 	(s)	The Subscriber has carefully read the Company’s filings with the Securities and Exchange Commission. The Subscriber has been given the opportunity to ask questions
of, and receive answers from, the Company concerning the terms and conditions of this offering and to obtain such additional information, to the extent the Company possesses such information or can acquire it without unreasonable effort or expense,
necessary to verify the accuracy of same as the undersigned reasonably desires in order to evaluate the investment. The Subscriber has had the opportunity to discuss any questions regarding any of the disclosure in Company’s filings with his
counsel or other advisor. The Subscriber does not desire to receive any further information. 

  

	 	(t)	The Subscriber is aware that the purchase of the Securities is a speculative investment involving a high degree of risk, that there is no guarantee that the undersigned
will realize any gain from this investment, and that the undersigned could lose the total amount of this investment. 

  

	 	(u)	The Subscriber represents that if an individual, he or she has adequate means of providing for his or her current needs and personal and family contingencies and has no
need for liquidity in this investment in the Securities. The Subscriber has no reason to anticipate any material change in his or her personal financial condition for the foreseeable future. 

 

	 	(v)	The Subscriber is financially able to bear the economic risk of this investment, including the ability to hold the Securities indefinitely, or to afford a complete loss
of the investment in the Securities. 

  

	 	(w)	The Subscriber represents that the undersigned’s overall commitment to investments which are not readily marketable is not disproportionate to the
Subscriber’s net worth, and the Subscriber’s investment in the Securities will not cause such overall commitment to become excessive. The undersigned understands that the statutory basis on which the Securities are being sold to the
undersigned and others would not be available if the undersigned’s present intention were to hold the Securities for a fixed period or until the occurrence of a certain event. The undersigned realizes that in the view of the Securities and
Exchange Commission (the “Commission”), a purchase now with a present intent to resell by reason of a foreseeable specific contingency or any anticipated change in the market value, or in the condition of the Company, or that of the
industry in which the business of the Company is engaged or in connection with a contemplated liquidation, or settlement of any loan obtained by the undersigned for the acquisition of the Subscriber, and for which such Subscriber may be pledged as
security or as donations to religious or charitable institutions for the purpose of securing a deduction on an income tax return, would, in fact, represent a purchase with an intent inconsistent with the undersigned’s representations to the
Company, and the Commission would then regard such sale as a sale for which the exemption from registration is not available. The undersigned will not pledge, transfer or assign this Subscription Agreement. 

7. Acknowledgement and Waiver. The Subscriber has acknowledged that the decision to purchase the Securities was solely made on the basis of
available information provided to the Subscriber. The Subscriber hereby waives, to the fullest extent permitted by law, any rights of withdrawal, rescission or compensation for damages to which the Subscriber might be entitled in connection with the
distribution of the Securities. 

  
 8. Representations and
Warranties will be Relied Upon by the Company. The Subscriber acknowledges that the representations and warranties contained herein are made by the undersigned with the intention that they may be relied upon by the Company and its legal
counsel in determining the undersigned’s eligibility to acquire the Securities under relevant legislation. The undersigned further agrees that by accepting delivery of the Securities, the undersigned will be representing and warranting that the
foregoing representations and warranties are true and correct as at the time of delivery of such Securities with the same force and effect as if they had been made by the undersigned at such time, and that they shall survive the completion of the
transactions contemplated under this Subscription and remain in full force and effect thereafter for the benefit of the Company for a period of one year. 
 9. Legend 
  

	9.1	The Subscriber hereby acknowledges that upon the issuance thereof, and until such time as the same is no longer required under the applicable securities laws and
regulations, the certificates representing the Shares and Underlying Shares will bear a legend in substantially the following form: 

 “NONE OF THE SECURITIES TO WHICH THIS CERTIFICATE RELATES HAVE BEEN REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD IN THE
UNITED STATES OR, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE
ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN ACCORDANCE WITH THE 1933 ACT.” 

 

	9.2	Subscriber hereby acknowledges and agrees to the Company making a notation on its records or giving instructions to the registrar and transfer agent of the Company in
order to implement the restrictions on transfer set forth and described in this Agreement. 

 10.
Costs. The Company shall be responsible for, and shall either pay directly or reimburse Subscriber for, one-half
( 1/2) of Subscriber’s expenses (including
any fees and disbursements of any special counsel retained by the Subscriber) incurred in connection with this Agreement and the transactions contemplated hereby. 
 11. Governing Law. This Agreement is governed by the laws of the State of Florida. The Subscriber, in its personal or corporate capacity and, if applicable, on behalf of each beneficial
purchaser for whom it is acting, irrevocably attorns to the jurisdiction of the courts of the State of Florida. 
 12. Survival.
This Agreement, including without limitation the representations, warranties and covenants contained herein, shall survive and continue in full force and effect and be binding upon the parties hereto notwithstanding the completion of the purchase of
the Securities by the Subscriber pursuant hereto. 
 13. Assignment. This Agreement is not transferable or assignable. 

  
 14. Severability. The
invalidity or unenforceability of any particular provision of this Agreement shall not affect or limit the validity or enforceability of the remaining provisions of this Agreement. 
 15. Entire Agreement. Except as expressly provided in this Agreement and in the agreements, instruments and other documents contemplated or provided for herein, this Agreement contains the
entire agreement between the parties with respect to the sale of the Securities and there are no other terms, conditions, representations or warranties, whether expressed, implied, oral or written, by statute or common law, by the Company or by
anyone else. 
 16. Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been
duly given if mailed or transmitted by any standard form of telecommunication. Notices to the Subscriber shall be directed to the address on the signature page of this Agreement and notices to the Company shall be directed to it at FNDS3000 Corp,
4651 Salisbury Road, Suite 485, Jacksonville, FL 32256, U.S.A., Attention: Joseph F. McGuire, Chief Financial Officer; copy to: Stephen M. Fleming, Fleming PLLC, 49 Front Street, Suite 206, Rockville Centre, New York 11570; Attention: Stephen M.
Fleming, Esq. 
 17. Counterparts and Electronic Means. This Agreement may be executed in any number of counterparts, each of
which, when so executed and delivered, shall constitute an original and all of which together shall constitute one instrument. Delivery of an executed copy of this Agreement by electronic facsimile transmission or other means of electronic
communication capable of producing a printed copy will be deemed to be execution and delivery of this Agreement as of the date hereinafter set forth. 
 18. Currency. Unless otherwise provided, all dollar amounts referred to in this Agreement are in lawful money of the United States of America. 

(signatures on the following page) 

  
 IN WITNESS WHEREOF the
Subscriber has duly executed this Agreement as of the date of acceptance by the Company. 
  

	
	 SHERINGTON HOLDINGS, LLC

	(Name of Subscriber – Please type or print)
	
	  

	(Signature and, if applicable, Title)
	
	  

	(Address of Subscriber)
	
	  

	(City, State or Province, Postal Code of Subscriber)
	
	  

	(Country of Subscriber)

 A C C E P T
A N C E 
 The above-mentioned Agreement in respect of the Securities is hereby accepted by FNDS3000 Corp DATED at
            , the      day of October, 2010. 
  

			
	FNDS3000 CORP
		
	Per:	 	  

		 	Name: Joe McGuire
		
		 	Title: Chief Financial Officer

  
 EXHIBIT A

 Form of Warrant 
 (attached) 

  
 EXHIBIT B

 Accredited Investor Questionnaire 
 The Company will rely on the information contained in this Questionnaire. 
 The undersigned
Subscriber covenants, represents and warrants to the Company that: 
  

	 	1.	the Subscriber has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of the Transaction and the
Subscriber is able to bear the economic risk of loss arising from such Transaction; 

  

	 	2.	the Subscriber satisfies one or more of the categories of “accredited investor” indicated below (please check the appropriate box): 

 

	 	 ̈	an individual who, either alone or with a spouse, beneficially owns, directly or indirectly, financial assets having an aggregate realizable value that, before taxes,
but net of any related liabilities, exceeds $1,000,000; 

  

	 	 ̈	an individual whose net income before taxes exceeded $200,000 in each of the two more recent calendar years or whose net income before taxes combined with that of a
spouse exceeded $300,000 in each of those years and who, in either case, reasonably expects to exceed that net income level in the current calendar year; 

  

	 	 ̈	an individual who, either alone or with a spouse, has net assets of at least $5,000,000; 

 

	 	 ̈	an entity, other than an individual or investment fund, that has net assets of at least $5,000,000 as shown on its most recently prepared financial statements;

  

	 	 ̈	an entity registered under the securities legislation of a jurisdiction of Canada as an advisor or dealer, other than a person registered solely as a limited market
dealer under one or both of the Securities Act (Ontario) or the Securities Act (Newfoundland and Labrador), or any entity organized in a foreign jurisdiction that is analogous to any such person or entity; or 

 

	 	 ̈	an entity in respect of which all of the owners of interests, direct, indirect or beneficial, except the voting securities required by law to be owned by directors, are
persons or companies that are accredited investors. 

 The Subscriber acknowledges and agrees that the Subscriber may be required
by the Company to provide such additional documentation as may be reasonably required by the Company and its legal counsel in determining the Subscriber’s eligibility to acquire the Securities under relevant securities legislation. 

IN WITNESS WHEREOF, the undersigned has executed this Questionnaire as of the      day of
            , 2010. 
  

					
	If a Corporation, Partnership or Other Entity:	 		 	If an Individual:
			
	 SHERINGTON HOLDINGS, LLC
	 		 	  

	Print or Type Name of Entity	 		 	Signature
			
	  
	 		 	  

	Signature of Authorized Signatory	 		 	Print or Type Name
			
	 Florida limited liability company
	 		 	
	Type of EntityFifth Amended and Restated Warrant to Purchase Common Stock

  
 Exhibit 4.2

 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) NOR UNDER ANY STATE SECURITIES LAW AND MAY
NOT BE PLEDGED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO REGISTRATION OR AN EXEMPTION THEREFROM. 

FIFTH AMENDED AND RESTATED WARRANT TO PURCHASE COMMON STOCK 

OF 

FNDS3000 CORP 
 This is
to Certify That, FOR VALUE RECEIVED, Sherington Holdings, LLC or its assigns (collectively, “Holder”), is entitled to purchase, at any time and from time to time during the Exercise Period (as defined in Section (a) below), and
subject to the provisions of this warrant (this “Fifth Amended and Restated Warrant”), from FNDS3000 Corp, a Delaware corporation (the “Company”), an aggregate of 9,254,360 fully paid, validly issued and
nonassessable shares (the “Warrant Shares”) of common stock of the Company (the “Common Stock”), at a price equal to Seventeen and One-Half Cents ($0.175) per share. Notwithstanding the foregoing, this Fifth Amended
and Restated Warrant shall not be exercisable by Holder unless and until there has occurred a full or partial exercise of (i) any of the 52,000 warrants for Common Stock (as amended or restated from time to time) that the Company hereby
represents and warrants were outstanding as of July 1, 2009 and are currently outstanding and exercisable (as set forth on Exhibit A hereto); the 4,000,000 warrants for Common Stock (as amended or restated from time to time) that the Company
issued to Bank Julius Baer & Co. Ltd., as of June 16, 2010; or the 1,000,000 warrants for Common Stock (as amended or restated from time to time) that the Company issued to Pierre Besuchet pursuant to that certain Fee Agreement dated
May 20, 2010 (collectively, the “Outstanding Warrants”), or (ii) any of an aggregate of 2,455,159 stock options to purchase Common Stock (as amended or restated from time to time) that the Company hereby represents and
warrants were outstanding as of July 1, 2009 and are currently outstanding and exercisable (as set forth on Exhibit B hereto) (the “Outstanding Options”), or (iii) any other options, warrants or other securities
convertible into Common Stock not included in (i) or (ii) above but that were outstanding as of July 1, 2009 (but excluding the warrants issued in connection with the private placements of Common Stock on July 1,
2009, November 2, 2009, November 30, 2009, and of even date herewith and any convertible notes outstanding and issued to Holder) (if any, the “Other Outstanding Convertible Securities”) (such Outstanding Warrants
and Outstanding Options and Other Outstanding Securities having been issued to persons not affiliated with Holder). Furthermore, any exercise of this Fifth Amended and Restated Warrant by Holder may be for up to (and not exceeding) a number of
Warrant Shares such that, giving effect to such exercise, there would result a fraction of .5521, the numerator of which being the aggregate number of Warrant Shares so exercised under this Warrant through such time, and the denominator of which
being the sum of (i) the aggregate of all Warrant Shares so exercised under this Warrant through such time, plus (ii) the aggregate number of shares of Common Stock for which Outstanding Warrants have been exercised through such time, plus
(iii) the aggregate number of shares of Common Stock for which Outstanding Options have been exercised through such time, plus (iv) the aggregate number of shares of Common Stock for which Other Outstanding Convertible Securities have been
exercised through such time; i.e., Holder shall have the ability, upon any exercise of this Warrant, to acquire up to 55.21% of all Common Stock issued pursuant to the exercise of Outstanding Options, Outstanding

 
Warrants, Other Outstanding Convertible Securities and this Warrant, in the aggregate through such date of, and giving effect to, such exercise. The Company shall provide written notice promptly,
and in any event within five (5) days, of any full or partial exercise of the Outstanding Warrants or Outstanding Options or Other Outstanding Convertible Securities, which notice shall provide Holder with the number of shares of Common Stock
for which Oustanding Warrants or Outstanding Options or Other Outstanding Convertible Securities are exercised, as the case may be, and the identity of the persons who have so exercised. 

The number of shares of Common Stock to be received upon exercise of this Fifth Amended and Restated Warrant and the price to be paid for
each share of Common Stock may be adjusted from time to time as hereinafter set forth. The exercise price of a share of Common Stock in effect at any time and as adjusted from time to time is hereinafter sometimes referred to as the
“Exercise Price”. 
 This Fifth Amended and Restated Warrant amends and restates in is entirety that certain
Fourth Amended and Restated Warrant to Purchase Common Stock of the Company dated June 16, 2010 (the “Existing Warrant”), it being the intention of the parties that all of the terms of the Existing Warrant, as amended hereby,
are restated in and are replaced by the terms of this Fifth Amended and Restated Warrant, but this Fifth Amended and Restated Warrant shall not be deemed or construed to have been issued in payment, satisfaction, cancellation or novation of the
Existing Warrant. 
 (a) EXERCISE OF WARRANT. This Fifth Amended and Restated Warrant may be exercised in whole or in part at
any time and from time to time beginning on October     , 2010 (the “Issue Date”) through December 31, 2013 (the “Exercise Period”). This Fifth Amended and Restated Warrant may be
exercised, in whole or in part, by written notice of such exercise (each, an “Exercise Notice”) to the Company at its principal office with the Purchase Form annexed hereto duly executed and accompanied by payment of the Exercise
Price for the number of Warrant Shares specified in such form. As soon as practicable after each such exercise of the warrants, the Company shall issue and deliver to the Holder a certificate or certificates for the Warrant Shares issuable upon such
exercise, registered in the name of the Holder or its designee. Upon receipt by the Company of an Exercise Notice and the appropriate aggregate Exercise Price for the applicable amount of Common Stock at its office in proper form for exercise, the
Holder shall be deemed to be the holder of record of the shares of Common Stock issuable upon such exercise, notwithstanding that the stock transfer books of the Company shall then be closed or that certificates representing such shares of Common
Stock shall not then be physically delivered to the Holder. On or before the first business day following the date on which the Company has received the Exercise Notice and the Exercise Price, the Company shall transmit by facsimile to Holder
(i) an acknowledgment of confirmation of receipt of the Exercise Notice and (ii) a capitalization table showing in detail the names, addresses, ownership, voting or other interests of all outstanding equity securities of the Company and
instruments convertible into Common Stock and any other equity securities of the Company, and the calculation of the number of Warrant Shares to be issued pursuant to this Fifth Amended and Restated Warrant. 

(b) RESERVATION OF SHARES. The Company covenants and agrees that all shares of Common Stock which may be issued upon exercise of this
Fifth Amended and Restated Warrant will, upon issuance, be duly authorized and validly issued, fully paid and nonassessable, and no personal liability will attach to the holder thereof. The Company shall at all times reserve solely for issuance
and/or delivery upon exercise of this Fifth Amended and Restated Warrant such number of shares of its Common Stock as shall be required for issuance and delivery upon exercise of this Fifth Amended and Restated Warrant; and if at any time the number
of authorized but unissued shares of Common Stock shall be insufficient to effect the issuance of the Warrant Shares, the Company shall take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but
unissued shares of Common Stock to such number of shares as shall be sufficient for such purpose. 

  
 (c) FRACTIONAL SHARES.
No fractional shares or script representing fractional shares shall be issued upon the exercise of this Fifth Amended and Restated Warrant, but rather the number of shares of Common Stock to be issued shall be rounded up to the nearest whole number.

 (d) EXCHANGE, TRANSFER, ASSIGNMENT OR LOSS OF WARRANT. This Fifth Amended and Restated Warrant is assignable (in whole, but
not in part), at the option of the Holder. Upon surrender of this Fifth Amended and Restated Warrant to the Company at its principal office, with the Assignment Form annexed hereto duly executed, the Company shall, without charge, execute and
deliver a new Warrant in the name of the assignee named in such instrument of assignment and this Fifth Amended and Restated Warrant shall promptly be canceled. The term “Fifth Amended and Restated Warrant” as used herein includes
any Warrants into which this Warrant may be divided or exchanged. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Fifth Amended and Restated Warrant, and (in the case of loss, theft or
destruction) receipt by the Company of indemnification reasonably satisfactory to it, and upon surrender and cancellation of this Fifth Amended and Restated Warrant, if mutilated, the Company will execute and deliver a new Warrant of like tenor and
date. Any such new Warrant executed and delivered shall constitute an additional contractual obligation on the part of the Company, whether or not this Warrant so lost, stolen, destroyed, or mutilated shall be at any time enforceable by anyone.

 (e) RIGHTS OF THE HOLDER. The Holder shall not, by virtue hereof, be entitled to any rights of a stockholder in the Company
in excess of those already vested in Holder as of the date hereof, either at law or equity. 
 (f) ANTI-DILUTION PROVISIONS. The
number of shares of Common Stock purchasable upon the exercise of this Fifth Amended and Restated Warrant shall be subject to adjustment from time to time thereafter upon the happening of certain events as follows: 

(i) Dividends, Splits, Combinations, Reclassifications. In the event the Company shall hereafter (A) pay a stock dividend or
make a stock distribution of shares of Common Stock with respect to the Common Stock, (B) subdivide its outstanding Common Stock into a greater amount of Common Stock, (C) combine its outstanding Common Stock into a smaller amount of
Common Stock, or (D) issue by reclassification of its Common Stock any other security of the Company, the Exercise Price in effect immediately prior to such action shall be adjusted so that Holder shall be entitled to receive the amount of
Common Stock or other capital stock of the Company it would have owned immediately following such action had this Fifth Amended and Restated Warrant or any remaining portion hereof been converted in full immediately prior thereto. All adjustments
made pursuant to this Section (f)(i) shall become effective immediately after the record date in the case of a dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or
reclassification. If, as a result of an adjustment made pursuant to this Section (f)(i), Holder shall become entitled to receive the Warrant Shares and other securities of the Company, the Board of Directors of the Company shall reasonably determine
the allocation of the adjusted Exercise Price between or among the Warrant Shares and such other securities. If the amount of any single adjustment of the Exercise Price required pursuant to this Section (f)(i) would be less than one cent ($.01) at
the time such adjustment is otherwise so required to be made, such amount shall be carried forward and adjustment with respect thereto made at the time of and together with any subsequent adjustment which, together with such amount and any other
amount or amounts so carried forward, shall aggregate at least one cent ($.01) when the Exercise Price is subsequently adjusted. 

  
 (ii) Sale of Shares
of Common Stock Below Exercise Price. If at any time or from time to time after the date this Fifth Amended and Restated Warrant is issued, the Company issues or sells, or is deemed by the express provisions of this Section (f)(ii) to have
issued or sold, Additional Shares of Common Stock (as hereinafter defined), other than as a dividend or other distribution on any class of stock as provided in Section (f)(i) above, and other than a subdivision or combination of shares of Common
Stock as provided in Section (f)(i) above, for an Effective Price (as hereinafter defined) less than the Exercise Price (subject to adjustment for any events after the Issue Date described in Section (f)(i)), then the then existing Exercise Price
shall be reduced, as of the opening of business on the date of such issue or sale, to a price equal to the Effective Price. 
 (A) Determination of Consideration. For the purpose of making any adjustment required under this Section (f)(ii), the consideration received by the Company for any issue or sale of securities shall
(1) to the extent it consists of cash, be the amount of cash received by the Company therefor before deducting any discounts, commissions or other expenses allowed, paid or incurred by the Company for any underwriting or otherwise in connection
thereof, (2) to the extent it consists of property other than cash, be computed at the fair value of that property as determined in good faith by the Board of Directors, and (3) if Additional Shares of Common Stock, Convertible Securities
(as hereinafter defined) or rights or options to purchase either Additional Shares of Common Stock or Convertible Securities are issued or sold together with other stock or securities or other assets of the Company for a consideration which covers
both, be computed as the portion of the consideration so received that may be reasonably determined in good faith by the Board of Directors to be allocable to such Additional Shares of Common Stock, Convertible Securities or rights or options.

 (B) Treatment of Convertible Securities. For the purpose of the adjustment required under this Section
(f)(ii), if the Company issues or sells any rights or options for the purchase of, or stock or other securities convertible into, Additional Shares of Common Stock (such convertible stock or securities being herein referred to as
“Convertible Securities”) and if the Effective Price of such Additional Shares of Common Stock is less than the Exercise Price (subject to adjustment as aforesaid), in each case the Company shall be deemed to have issued at the time
of the issuance of such rights or options or Convertible Securities the maximum number of Additional Shares of Common Stock issuable upon exercise or conversion thereof and to have received as consideration for the issuance of such shares an amount
equal to the total amount of the consideration, if any, received by the Company for the issuance of such rights or options or Convertible Securities, plus, in the case of such rights or options, the amounts of consideration, if any, payable to the
Company upon the exercise of such rights or options, plus, in the case of Convertible Securities, the amounts of consideration, if any, payable to the Company (other than by cancellation of liabilities or obligations evidenced by such Convertible
Securities) upon the conversion thereof; provided that if, in the case of Convertible Securities, the amounts of such consideration cannot be ascertained but are a function of anti-dilution or similar protective clauses, the Company shall be deemed
to have received the amounts of consideration without reference to such clauses; and provided further that if the amount of consideration payable to the Company upon the exercise or conversion of rights, options or Convertible Securities is reduced
over time or on the occurrence or non-occurrence of specified events other than by reason of anti-dilution adjustments, the Effective Price shall be recalculated using the figure to which such amount of consideration is reduced; and provided further
that if the amount of consideration payable to the Company upon the exercise or conversion of such rights, options or Convertible Securities is subsequently increased, the Effective Price shall be again recalculated using the increased amount of
consideration payable to the Company upon the exercise or conversion of 

 
such rights, options or Convertible Securities. No further adjustment of the Exercise Price, as adjusted upon the issuance of such rights, options or Convertible Securities, shall be made as a
result of the actual issuance of Additional Shares of Common Stock on the exercise of any such rights or options or the conversion of any such Convertible Securities. If any such rights or options or the conversion privilege represented by any such
Convertible Securities shall expire without having been exercised, the Exercise Price as adjusted upon the issuance of such rights, options or Convertible Securities shall be readjusted to the Exercise Price which would have been in effect had an
adjustment been made on the basis that the only Additional Shares of Common Stock so issued were the Additional Shares of Common Stock, if any, actually issued or sold on the exercise of such rights or options or rights of conversion of such
Convertible Securities, and such Additional Shares of Common Stock, if any, were issued or sold for the consideration actually received by the Company upon such exercise, plus the consideration, if any, actually received by the Company for the
granting of all such rights or options, whether or not exercised, plus the consideration received for issuing or selling the Convertible Securities actually converted, plus the consideration, if any, actually received by the Company (other than by
cancellation of liabilities or obligations evidenced by such Convertible Securities) on the conversion of such Convertible Securities, provided that such readjustment shall not apply to prior exercises of this Fifth Amended and Restated Warrant.

 (C) Excluded Issuances. For purposes of this Fifth Amended and Restated Warrant, the term
“Additional Shares of Common Stock” shall mean all shares of Common Stock issued by the Company or deemed to be issued pursuant to this Section (f)(ii), whether or not subsequently reacquired or retired by the Company other than
(1) shares of Common Stock issued upon exercise of this Fifth Amended and Restated Warrant; and (2) shares of Common Stock issued pursuant to the exercise of options, warrants or convertible securities outstanding as of the date this Fifth
Amended and Restated Warrant is issued. 
 (D) Effective Price. For purposes of this Fifth Amended and
Restated Warrant, the term “Effective Price” of Additional Shares of Common Stock shall mean the quotient determined by dividing the total number of Additional Shares of Common Stock issued or sold, or deemed to have been issued or
sold by the Company under this Section (f)(ii), into the aggregate consideration received, or deemed to have been received by the Company for such issue under this Section (f)(ii), for such Additional Shares of Common Stock. 

(iii) Whenever the number of Warrant Shares are adjusted, as herein provided, the Company shall promptly, but no later than twenty
(20) days after the consummation of the event giving rise to such adjustment, cause a notice setting forth the adjusted Warrant Shares issuable upon exercise of each Warrant and information describing the transactions giving rise to such
adjustments to be mailed by certified mail to the Holder. Each such notice shall also be made available at all reasonable times for inspection by any Holder of a Warrant executed and delivered pursuant to Section (a). The Company may retain a firm
of independent certified public accountants selected by the Board of Directors (who may be the regular accountants employed by the Company) to make any computation required by this Section (f), and a certificate signed by such firm shall be
conclusive evidence of the correctness of such adjustment. 
 (iv) In the event that at any time, as a result of an adjustment
made pursuant to this Section (f), the Holder of this Fifth Amended and Restated Warrant thereafter shall become entitled to receive any shares of the Company, other than Common Stock, thereafter the number of such other shares so receivable upon
exercise of this Fifth Amended and Restated Warrant shall be subject to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the Common Stock contained in this Section (f).

  
 (v) Irrespective of
any adjustments made in the number of Warrant Shares issuable upon the exercise of this Fifth Amended and Restated Warrant, Warrants theretofore issued may continue to express the same price and number and kind of shares as are stated in the similar
Warrants initially issuable pursuant to this Agreement. 
 (g) NOTICES TO WARRANT HOLDERS. So long as this Fifth Amended and
Restated Warrant shall be outstanding, (i) if the Company shall pay any dividend or make any distribution upon the Common Stock or (ii) if the Company shall offer to the holders of Common Stock for subscription or purchase by them any
share of any class or any other rights or (iii) if any capital reorganization of the Company, reclassification of the capital stock of the Company, consolidation or merger of the Company with or into another corporation, sale, lease or transfer
of all or substantially all of the property and assets of the Company to another entity, or voluntary or involuntary dissolution, liquidation or winding up of the Company shall be effected, then in any such case, the Company shall cause to be mailed
by certified mail to the Holder, at least fifteen (15) days prior the date specified in (x) or (y) below, as the case may be, a notice containing a brief description of the proposed action and stating the date on which (x) a
record is to be taken for the purpose of such dividend, distribution or rights, or (y) such reclassification, reorganization, consolidation, merger, conveyance, lease, dissolution, liquidation or winding up is to take place and the date, if any
is to be fixed, as of which the holders of Common Stock or other securities shall receive cash or other property deliverable upon such reclassification , reorganization, consolidation, merger, conveyance, dissolution, liquidation or winding up.

 (h) RECLASSIFICATION, REORGANIZATION OR MERGER. In case of any reclassification, capital reorganization or other similar
change of the outstanding shares of capital stock of the Company, consolidation or merger of the Company with or into another corporation (other than a merger with a subsidiary in which merger the Company is the continuing corporation and which does
not result in any reclassification, capital reorganization or other change of outstanding shares of Common Stock of the class issuable upon exercise of this Fifth Amended and Restated Warrant) or in case of any sale, lease or conveyance to another
corporation of all or substantially all the assets of the Company resulting in any distribution to the Company’s stockholders, the Company shall cause effective provisions to be made so that the Holder shall have the right thereafter by
exercising this Fifth Amended and Restated Warrant at any time prior to the expiration of this Fifth Amended and Restated Warrant, to purchase the kind and amount of shares of stock, and other securities and property receivable upon such
reclassification, capital reorganization and other change, consolidation, merger, sale or conveyance by a holder of the number of shares of Common Stock which might have been purchased upon exercise of this Fifth Amended and Restated Warrant
immediately prior to such reclassification, change, consolidation, merger, sale or conveyance. Any such provision shall include provision for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided for in
this Fifth Amended and Restated Warrant. The foregoing provisions of this Section (h) shall similarly apply to successive reclassifications, capital reorganizations and changes of shares of the Company’s capital stock and to successive
consolidations, mergers, sales or conveyances. In the event that in connection with any such capital reorganization or reclassification, consolidation, merger, sale or conveyance, additional shares of Common Stock shall be issued in exchange,
conversion, substitution or payment, in whole or in part, for a security of the Company other than Common Stock, any such issue shall be treated as an issue of Common Stock covered by the provisions of Section (f)(i) hereof. 

(i) REGISTRATION RIGHTS. The Holder of this Fifth Amended and Restated Warrant or of the Warrant Shares shall have the registration
rights set forth in the Registration Rights Agreement 

 
between the parties dated January 6, 2009, as amended by that certain First Amendment to Registration Rights Agreement dated as of July 1, 2009, that certain Second Amendment to
Registration Rights Agreement dated as of November 2, 2009, that certain Third Amendment to Registration Rights Agreement dated as of November 30, 2009, that certain Fourth Amendment to Registration Rights Agreement dated as of
April 8, 2010, that certain Fifth Amendment to Registration Rights Agreement dated June 16, 2010, and that certain Sixth Amendment to Registration Rights Agreement of even date herewith. 

(j) NOTICES. All notices or other communications which are required or permitted hereunder shall be in writing and sufficient if
delivered personally, by facsimile or sent by overnight express or by registered or certified mail, postage prepaid, addressed as follows: 
  

			
	If to the Company:	  	 FNDS3000 Corp
 4651
Salisbury Road, Suite 485

		  	Jacksonville, FL 32256
		  	Attention: Joseph F. McGuire
		  	Telephone: 904-273-2702
		  	Facsimile: 904-273-7231
		
	With a copy to:	  	Law Offices of Stephen M. Fleming PLLC
		  	49 Front Street, Suite 206
		  	Rockville Centre, New York 11570
		  	Attention: Stephen M. Fleming
		  	Telephone: 516-833-5034
		  	Facsimile: 516-977-1209
		
	If to Holder:	  	Sherington Holdings, LLC
		  	60 Sherington Place
		  	Atlanta, GA 30350
		  	Attention: Raymond Goldsmith
		  	Facsimile: 678-805-2501
		
	With copy to:	  	Troutman Sanders LLP
		  	600 Peachtree Street, N.E.
		  	Suite 5200
		  	Atlanta, GA 30308-2216
		  	Attention: John W. Stephenson Jr.
		  	Telephone: (404) 885-3602
		  	Facsimile: (404) 962-6728
		  	Email: john.stephenson@troutmansanders.com

Each party shall provide notice to the other party of any change in address. 

(k) INVESTMENT. The Holder hereof covenants and agrees that this Fifth Amended and Restated Warrant has been taken for investment and for
its own account and not with a view toward resale or distribution within the meaning of the Securities Act of 1933, as amended or any state securities law. Furthermore, such Holder acknowledges that the certificate(s) representing the shares of
Common Stock issuable upon exercise of this Fifth Amended and Restated Warrant will bear a legend accordingly. 

  
 (l) NONCIRCUMVENTION.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale
of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Fifth Amended and Restated Warrant. 

IN WITNESS WHEREOF, the Company has caused this Fifth Amended and Restated Warrant to be signed in its name by
its duly authorized officers effective as of the 19th day
of October, 2010. 
  

					
	COMPANY:
	
	FNDS3000 CORP
		
	By:	 	  

		 	Name:	 	Joe McGuire
		 	Title:	 	Chief Financial Officer

  

			
	Attest:
	
	  

	Name:	 	
	Title:	 	

  
 PURCHASE FORM

 Dated
                     

The undersigned hereby irrevocably elects to exercise the within Warrant to the extent of purchasing
             shares of Common Stock and hereby makes payment of              in payment of the actual price
thereof. 
  
  

INSTRUCTIONS FOR REGISTRATION OF STOCK 
  

			
	Name	 	  

	(Please typewrite or print in block letters)
		
	Address	 	  

		
	Signature	 	  

 WARRANT EXCHANGE 
 The undersigned, pursuant to the Warrant Exchange
provisions of the foregoing Warrant, hereby elects to exchange its Warrant for              shares of Common Stock. 
 Date:                      

 

	
	  

	Print Name
	
	  

	Address
	
	  

	Signature

  
 ASSIGNMENT FORM

 FOR VALUE RECEIVED,
                         hereby sells, assigns and transfers unto 

 

			
	Name	 	  

	(Please typewrite or print in block letters)
		
	Address	 	  

 the right to purchase Common Stock represented by this Warrant to the extent of              shares as to which such right is exercisable
and does hereby irrevocably constitute and appoint                          Attorney, to transfer the same on the books of
the Company with full power of substitution in the premises. 
  

			
	Date	 	  

		
	Signature	 	  

  
 Exhibit A

  

																	
	 Holder
	  	Issue Date	  	Shares	 	  	Term	  	Exercise
Price	 	  	Expiration
Date	 
	 Greg Garber
	  	12/06/08	  	 	52,000	  	  	2 year	  	$	0.250	  	  	 	12/06/10	  

  
 Exhibit B

  

																					
	 Holder
	  	Grant
Date	 	  	Term	 	  	Shares	 	  	Exercise
Price	 	  	Expiration
Date	 
	 Joe Tumbarello
	  	 	06/01/07	  	  	 	5 year	  	  	 	1,100,000	  	  	$	0.835	  	  	 	06/01/12	  
	 Lenus le Roux
	  	 	02/01/08	  	  	 	5 year	  	  	 	45,000	  	  	$	0.745	  	  	 	02/01/13	  
	 Joe Tumbarello
	  	 	05/07/08	  	  	 	5 year	  	  	 	100,000	  	  	$	0.190	  	  	 	05/07/13	  
	 Joe McGuire
	  	 	07/25/08	  	  	 	5 year	  	  	 	500,000	  	  	$	0.390	  	  	 	07/25/13	  
	 Joe McGuire
	  	 	10/15/08	  	  	 	5 year	  	  	 	500,000	  	  	$	0.400	  	  	 	10/15/13	  
	 Lenus Leroux
	  	 	10/01/08	  	  	 	5 year	  	  	 	35,000	  	  	$	0.450	  	  	 	10/01/13	  
	 Alex Braude
	  	 	09/26/08	  	  	 	5 year	  	  	 	85,159	  	  	$	0.440	  	  	 	09/26/13	  
	 Kotie Coetzee
	  	 	01/12/09	  	  	 	5 year	  	  	 	90,000	  	  	$	0.400	  	  	 	01/12/14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00179-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00179-of-00352.parquet"}]]